Loading…
Physician Pathology Services Continuity Act of 2011
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
7d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2013 · second_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $86,350 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · second_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Client expense: $86,350 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · second_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Client expense: $86,350 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · second_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Client expense: $86,350 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · first_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $113,052 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · first_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $113,052 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · first_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $113,052 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · first_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $113,052 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · fourth_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,827 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · fourth_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,827 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · fourth_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,827 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · fourth_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,827 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Health Issues
S 17 - Medical Device Access and Innovation Protection Act of 2011 HR 436 - Protect Medical Innovation Act of 2011 S 223 - FAA Air Transportation Modernization and Safety Improvement Act HR 658 - FAA Reauthorization and Reform Act of 2011 HR 2461 - Physician Pathology Services Continuity Act of 2011 HR 2020 and S 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832 - To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for Radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012 HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 HR 3269 - Diagnostic Imaging Services Access Protection Act of 2011 Helium Shortage S 1995 - Medical Device Patient Safety Act HR 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 S 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 S 2374 - Helium Stewardship Act of 2012 S3187 - Food and Drug Administration Safety and Innovation Act
Client expense: $3,890,000 · Firm income: Not reported
2012 · first_quarter · Health Issues
S 17 - Medical Device Access and Innovation Protection Act of 2011 HR 436 - Protect Medical Innovation Act of 2011 S 223 - FAA Air Transportation Modernization and Safety Improvement Act HR 658 - FAA Reauthorization and Reform Act of 2011 HR 2461 - Physician Pathology Services Continuity Act of 2011 HR 2020 and S 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832 - To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for Radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012 HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 HR 3269 - Diagnostic Imaging Services Access Protection Act of 2011 Helium Shortage S 1995 - Medical Device Patient Safety Act
Client expense: $5,280,000 · Firm income: Not reported
2012 · third_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $58,737 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $58,737 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $58,737 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $58,737 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · third_quarter · Medicare/Medicaid
H.R. 1543 and S. 818, Improving Access to Medicare Coverage Act of 2011, entire bill. H.R. 6365, the National Security and Job Protection Act of 2011, entire bill. H.R. 4872, the Health Care & Education Affordability Reconciliation Act of 2010: provisions relating to hospitals and physicians, including: Section 1106: physician-owned hospitals and self-referral; Section 2302: 340B program; Section 1104 and Section 1203: Medicare and Medicaid DSH Payments; Sections 1108 and 1109 involving geographic disparities in Medicare payment; Section 1105: Market basket updates; Section 1201: Federal funding for States; Section 1202: Payments to primary care physicians. H.R. 3590, the Patient Protection and Affordable Care Act, provisions relating to hospitals, hospice and physicians including: Section 3001: hospital value-based purchasing; Section 3125: low-volume hospital payment; Section 3401: productivity adjustments; Section 6001: physician-owned hospital and self-referral; Section 3121: outpatient hold harmless for hospitals; Sections 7101-7103: 340B Program; Section 3401: Independent Payment Advisory Board; Section 3015: hospital readmissions program; Section 3124: Extension of Medicare Dependent Hospital program; Section 3137: Section 508 Reclassification; Section 9007: non-profit hospital provision; Section 3105: ambulance services; Section 3008 and Section 2702: payment adjustment for hospital acquired conditions; Section 3133: Medicare DSH; Section 2551: Disproportionate Share Hospitals; Section 5501: Primary Care Provisions; Section 5503: Graduate Medical Education; Sections 2001-2081: Expansion of Medicaid, CHIP; Sections 1311-1343: CO-OPs and Exchanges; Section 3022: Accountable Care Organizations; Section 3023: Hospital Bundling Provision; Section 6401-6402: Program Integrity Provisions; Section 6501-6503, 6505, 6508: Medicaid Program Integrity Provisions. H.R. 2674, 340B Program Improvement Act, entire bill. S. 722 and H.R. 3506, Hospice Evaluation and Legitimate Payment Act, entire bills. S. 778, Protecting Access to Rural Therapy Services (PARTS) Act, entire bill. H.R. 3285, Medicare Equity Extension Act, entire bill. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011, Title II, Subtitle C--Medicare Extensions; Other Health Provisions, Part 1--Medicare extensions, Section 2201, Physician payment update. Section 2202: Ambulance Add-ons; Section 2203: Medicare payment for outpatient therapy services; Section 2204: Work geographic Adjustment; Part 3--Offsets, Section 2223: Parity in Medicare payments for hospital outpatient department evaluation and management office visit services; Section 2224, Reduction of bad debt treated as an allowable cost; Section 2225, Rebasing of State DSH allotments for FY 2021. Part 2 of Subtitle C--Other Health Provisions, Section 2213: Modification to requirements for qualifying for exception to Medicare prohibition on certain physician referrals for hospitals. H.R. 3859 and S. 1680, The Rural Hospital and Provider Equity (R-HOPE) Act of 2012, entire bills. H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2012, entire bill. H.R. 5943 and S. 2620, the Rural Hospital Access Act of 2012, entire bills. H.R. 2461, Physician Pathology Services Continuity Act of 2011, entire bill. H.R. 2104, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011, entire bill. 2013 Outpatient Prospective Payment System proposed rule, entire rule. 2013 Inpatient Prospective Payment System final rule, entire rule. 2013 Physician Fee Schedule proposed rule, entire rule. Other issues: Proposals surrounding the Sustainable Growth Rate (SGR) and deficit/debt reduction as related to hospitals and physicians. Accountable Care Organizations and the Innovation Center's demonstration programs. Medicare and Medicaid Recovery Audit Contractor programs. Geographic Variation in Medicare spending, IOM studies on high value and Medicare geographic adjusters. Medical Liability Reform. Medicare and Medicaid Electronic Health Record Payment Incentive Programs. Hospital wage index reform, including Section 3137(b) of the Affordable Care Act. Implementation of the state health insurance exchanges. 2013 Inpatient Rehab rule, entire rule. 2013 LTCH rule, entire rule Hospice Quality Reporting Program. 2013 Home Health rule, entire rule. Dual Eligible Demonstration Programs.
2012 · second_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
S 17 - Medical Device Access and Innovation Protection Act of 2011 HR 436 - Protect Medical Innovation Act of 2011 S 223 - FAA Air Transportation Modernization and Safety Improvement Act HR 658 - FAA Reauthorization and Reform Act of 2011 HR 2461 - Physician Pathology Services Continuity Act of 2011 HR 2020 and S 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832 - To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for Radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012 HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 HR 3269 - Diagnostic Imaging Services Access Protection Act of 2011 Helium Shortage S 1995 - Medical Device Patient Safety Act HR 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 S 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 S 2374 - Helium Stewardship Act of 2012 S3187 - Food and Drug Administration Safety and Innovation Act
Client expense: $4,860,000 · Firm income: Not reported
2012 · second_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $52,121 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Medicare/Medicaid
H.R. 4872, the Health Care & Education Affordability Reconciliation Act of 2010: provisions relating to hospitals and physicians, including: Section 1106: physician-owned hospitals and self-referral; Section 2302: 340B program; Section 1104 and Section 1203: Medicare and Medicaid DSH Payments; Sections 1108 and 1109 involving geographic disparities in Medicare payment; Section 1105: Market basket updates; Section 1201: Federal funding for States; Section 1202: Payments to primary care physicians. H.R. 3590, Patient Protection and Affordable Care Act, provisions relating to hospitals, hospice, and physicians including: Section 3001: hospital value-based purchasing; Section 3125: low-volume hospital payment; Section 3401: productivity adjustments; Section 6001: physician-owned hospital and self-referral; Section 3121: outpatient hold harmless for hospitals; Sections 7101-7103: 340B Program; Section 3403: Independent Payment Advisory Board; Section 3025: hospital readmissions provision; Section 3124: extension of Medicare Dependent Hospital program; Section 3137: Section 508 reclassification; Section 9007: non profit hospital provision; Section 3105: ambulance services; Section 3008 and Section 2702: payment adjustment for hospital acquired conditions; Section 3133: Medicare DSH; Section 2551: Disproportionate Share Hospitals; Section 5501: primary care provisions; Section 5503: Graduate Medical Education; Sections 2001-2081: expansion of Medicaid, CHIP; Sections 1311-1343: CO-OPs and Exchanges; Section 3022: accountable care organizations; Section 3023: hospital bundling provision; Section 6401-6402, Program Integrity Provisions; Section 6501-6503, 6505, 6508, Medicaid Program Integrity Provisions. H.R. 2674, 340B Program Improvement Act, entire bill. S. 722 and H.R. 3506, Hospice Evaluation and Legitimate Payment Act, entire bills. S. 778, Protecting Access to Rural Therapy Services (PARTS) Act, entire bill. H.R. 3285, Medicare Equity Extension Act, entire bill. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011, Title II, Subtitle C--Medicare Extensions; Other Health Provisions, Part 1--Medicare extensions, Section 2201. Physician payment update; Section 2202. Ambulance add-ons; Section 2203. Medicare payment for outpatient therapy services; Section 2204. Work geographic adjustment. Part 3--Offsets, Section 2223, Parity in Medicare payments for hospital outpatient department evaluation and management office visit services; Section 2224, Reduction of bad debt treated as an allowable cost; Section 2225, Rebasing of State DSH allotments for FY 2021. Part 2 of Subtitle C--Other Health Provisions, Sec. 2213. Modification to requirements for qualifying for exception to Medicare prohibition on certain physician referrals for hospitals. H.R. 3859 and S.1680, The Rural Hospital and Provider Equity (R-HOPE) Act of 2012, entire bills. H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2012, entire bill. H.R. 2461, Physician Pathology Services Continuity Act of 2011, entire bill. S. 3187, the FDA Safety and Innovation Act, entire bill. H.R. 5651, FDA Reform Act, entire bill. S. 2516, Food and Drug Administration Safety and Innovation Act, entire bill. H.R. 5943 and S. 2620, the Rural Hospital Access Act of 2012, entire bills. H.R. 876, Registered Nurse Safe Staffing Act of 2011, entire bill. H.R. 4966, Sequester Replacement Act of 2012, entire bill. H.R. 3839, the Drug Shortage Prevention Act, entire bill. H.R. 2245, the Preserving Access to Lifesaving Medications Act, entire bill. S. 1734, Generating Antibiotic Incentives Now Act of 2011, entire bill. 2012 Outpatient Prospective Payment System rule, focusing on provisions affecting physicians and hospitals including: policies related to the physician supervision of outpatient therapeutic services and hospital value-based purchasing program. 2012, 2013 Inpatient prospective payment system rules: entire rules. 2012 Hospice wage index proposed rule, entire rule. Changes to Hospital CoPs, entire rule. Reporting and Returning Medicare Overpayments, entire rule. Other issues: "Super Committee" deliberations related to S. 365, Budget Control Act of 2012. Proposals involving the Sustainable Growth Rate (SGR) formula. The Deficit Commission Report and President's 2013 budget proposal, including proposals that involve Medicare and Medicaid payments to hospitals. 2011 March CBO proposal to eliminate the CAH, SCH, MDH programs. Accountable Care Organizations regulations and the Innovation Center's demonstration programs. Medicare and Medicaid Recovery Audit Contractor programs. Geographic Variation in Medicare spending, IOM studies on high value and Medicare geographic adjusters. Medical Liability Reform. Medicare and Medicaid Electronic Health Record Payment Incentive Programs (Meaningful Use), including the release of the Stage 2 Meaningful Use regulation. Hospital wage index reform, including Section 3137(b) of the Affordable Care Act. Implementation of state health insurance exchanges.
2012 · first_quarter · Health Issues
S 17 - Medical Device Access and Innovation Protection Act of 2011 HR 436 - Protect Medical Innovation Act of 2011 S 223 - FAA Air Transportation Modernization and Safety Improvement Act HR 658 - FAA Reauthorization and Reform Act of 2011 HR 2461 - Physician Pathology Services Continuity Act of 2011 HR 2020 and S 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832 - To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for Radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine HR 3630 - Middle Class Tax Relief and Job Creation Act of 2012 HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 HR 3269 - Diagnostic Imaging Services Access Protection Act of 2011 Helium Shortage S 1995 - Medical Device Patient Safety Act
Client expense: $5,470,000 · Firm income: Not reported
2012 · first_quarter · Insurance
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medical/Disease Research/Clinical Labs
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Health Issues
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medicare/Medicaid
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Client expense: $79,630 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medicare/Medicaid
-HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing. -Sustained Growth Rate (SGR) Medicare Physician Payment Reform -Stark Self-Referral Law -HR 3765, The Temporary Payroll Tax Cut Continuation Act of 2011 - HR 2461, S.1967 - Physician Pathology Services Continuation Act - Extension of existing law to allow independent laboratories under certain conditions to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
Client expense: $427,944 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Health Issues
HR 408 - The Spending Reduction Act of 2011 S 17 - Medical Device Access and Innovation Protection Act of 2011 HR 436 - Protect Medical Innovation Act of 2011 S 223 - FAA Air Transportation Modernization and Safety Improvement Act HR 658 - FAA Reauthorization and Reform Act of 2011 HR 2461 - Physician Pathology Services Continuity Act of 2011 HR 2104 - Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 HR 2020 and S 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832 - To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for Radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine HR 3630 - Middle Class Tax Relief and Job Creation Act of 2011 HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 HR 3269 - Diagnostic Imaging Services Access Protection Act of 2011
Client expense: $5,330,000 · Firm income: Not reported
2011 · fourth_quarter · Medicare/Medicaid
H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing. - Sustained Growth Rate (SGR) Medicare Physician Payment Reform - Stark Self-Referral Law H.R. 2461, S.1967 - Physician Pathology Services Continuity Act - Extension of existing law to allow independent laboratories, under certain conditions, to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
Client expense: $246,401 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Health Issues
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Client expense: $56,116 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Medical/Disease Research/Clinical Labs
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Client expense: $56,116 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Medicare/Medicaid
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Client expense: $56,116 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Insurance
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Client expense: $56,116 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Health Issues
HR 408, The Spending Reduction Act of 2011 S 17, Medical Device Access and Innovation Protection Act of 2011 HR 436, Protect Medical Innovation Act of 2011 S 223, FAA Air Transportation Modernization and Safety Improvement Act HR 658, FAA Reauthorization and Reform Act of 2011 HR 2461, Physician Pathology Services Continuity Act of 2011 HR 2104, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 HR 2020 and S 1096, Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 HR 2832, To extend the Generalized System of Preferences, and for other purposes FDA 510(k) Reform Health Information Technology Medicare Reimbursement for Imaging Services Medicare Reimbursement for radiopharmaceuticals Medicare Coverage of New Technologies United States Preventive Services Task Force Issues Patient Safety Organizations Laboratory Developed Tests Physician Payments Sunshine
Client expense: $5,650,000 · Firm income: Not reported
| Republican |
| KS |
| Mike Ross | Democratic | AR |
| Pedro R. Pierluisi | Democratic | PR |
| Steve Womack | Republican | AR |
| Tim Griffin | Republican | AR |
| Tom Latham | Republican | IA |
| Vern Buchanan | Republican | FL |
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Client expense: $50,463 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Client expense: $62,554 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)